- Tytuł :
- Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial.
- Autorzy :
- Źródło :
- BMC Gastroenterology. 3/2/2021, Vol. 21 Issue 1, p1-10. 10p.
-
Czasopismo naukowe